Skip to main content

Table 5 Results on changes in cellular and/or signaling response to BMMSC cultivated constructs under hydrostatic compression (Fig. 2). Sox9 is the gene that regulates chondrogenic differentiation; h is hours; h/day is hours per day; − is decrease or inhibition; and + is increase; ++ is highest increase; = is no change or status quo

From: What quantitative mechanical loading stimulates in vitro cultivation best?

Study

Cell source, cultivated construct, additive(s)

Magnitude (MPa)

Freq (Hz)

Loading (h/day)

Loading (# days)

Loading (total h)

Culture composition (change -, =, +)

mRNA response (change -, =, +)

Mesh

Wagner 2008 (Wagner et al. 2008)

Human BMMSC, Mesh Collagen Type 1 50 mg/mL bovine serum albumin; 50 μg/mL L-ascorbic acid; 10−9 M dexamethasone

1

1

4

10

40

+ proteoglycan

+ Sox9

+ aggrecan

+ collagen II

Luo 2007 (Luo and Seedhom 2007)

Ovine BMMSC, Mesh non-woven filamentous plasma-treated polyester 10 % Fetal bovine serum; 50 μg/mL ascorbic acid; 10−7 M dexamethasone

0.1

0.25

0.5

7

3.5

+ GAG

 

= collagen

0.5

10

5

++ GAG

 

+ collagen

Gel

Miyanishi 2006a (Miyanishi et al. 2006a)

Human BMMSC, Aggregate pellet 1.25 mg/mL bovine serum albumin; 50 μg/mL ascorbic acid; 10−7 M dexamethasone

0.1

1

4

14

56

= sGAG

+ Sox9

+ aggrecan

= collagen II

1

+ sGAG

++ Sox9

+ aggrecan

= collagen II

10

++ sGAG

++ Sox9

++ aggrecan

+ collagen II

Miyanishi 2006b (Miyanishi et al. 2006b)

Human BMMSC, Aggregate pellet 1.25 mg/mL bovine serum albumin; 50 cpg/mL ascorbic acid; 10−7 M dexamethasone

10

1

4

14

56

 

+ Sox9

+ aggrecan

+ collagen II

Angele 2003 (Angele et al. 2003)

Human BMMSC, Aggregate pellet 10 % Fetal bovine serum

5.03

1

4

1

4

= proteoglycan

 

= collagen

4

7

28

+ proteoglycan

 

+ collagen

Finger 2007 (Finger et al. 2007)

Human BMMSC, Agarose gel Type VII Growth medium Cambrex

7.5

1

4

14

56

 

= Sox9